electroCore, Inc.NASDAQ: ECOR

electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub

· Issued by electroCore, Inc. via GlobeNewswire

Summary by 6ix AI

electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, will present at Planet MicroCap Toronto 2026 Powered by MicroCapClub, held October 27-29 at the Arcadian Court & Loft in Toronto.

Key details

  • Co-CEO, President and CFO Joshua Lev will give the presentation on Wednesday, October 28 at 9:30 am ET and will hold one-on-one investor meetings throughout the conference.
  • The presentation will be webcast.

6ix AI wrote this summary from the release below and checked it against the release.

ROCKAWAY, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Toronto 2026 Powered by MicroCapClub being held at the Arcadian Court & Loft.  Joshua Lev, Co-CEO, President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.

Conference Details:

Dates:  October 27-29 Company Presentation:  Wednesday, October 28 at 9:30 am ETLocation:  Arcadian Court & Loft, 401 Bay St., Simpson Tower, 8th Floor Toronto, ON, M5H 2Y4Webcast:  https://event.summitcast.com/view/iiVo9HYfz9sL9CC5m4Dgpv/N22s45azRsLw3U5aeUR5NF

If you would like to book one-on-one investor meetings with electroCore and attend Planet MicroCap Toronto 2026, please register at https://planetmicrocap.com.

About electroCore, Inc.

electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com.

Contact: ECOR Investor Relations(973) [email protected]

Primary Logo

Source: electroCore, Inc.

electroCore, Inc. on 6ix

Story so far

Earlier from electroCore

Later from electroCore

All electroCore news releases